MoonLake’s nanobody boosts all clinical endpoints in phase 3 psoriatic arthritis trial
Who reported it (5)
- MoonLake's psoriatic arthritis drug meets key goals in late-stage trial marketscreener.com · 15d ago
- Sonelokimab Meets Primary End Point in Phase 3 Psoriatic Arthritis Trial Dermatology Times · 15d ago
- MoonLake Immunotherapeutics Announces Q2 2026 Financial Results with Increased Net Loss and Cash Reserves Kalkine Media · 15d ago
- MoonLake touts Phase III PsA data, but investors may have wanted more FirstWord Pharma · 15d ago
- MoonLake’s nanobody boosts all clinical endpoints in phase 3 psoriatic arthritis trial Fierce Biotech · 15d ago broke it first
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
Related trends
Dick's Sporting Goods misses revenue expectations, citing 'challenging' footwear market
Dick’s Sporting posts $17.22 B FY25 sales yet misses forecasts as a tough footwear market tests its Foot Locker integration.
Lego posts record first-half revenue, CEO touts strong sales at high-end and value pricing
Lego's record first‑half revenue, driven by World Cup and premium sets, spotlights a booming toy market.
Druckenmiller, Bessent’s Early Mentor, Calls Bond Buys a Mistake
Stanley Druckenmller brands the U.S. Treasury’s latest bond buyback a credibility‑killing mistake, sparking fresh market debate.
Starbucks’ Pumpkin Spice Latte Is Back, Along With 6 All-New Drinks—and We Tried Them First
Starbucks rolls out its 2026 Pumpkin Spice Latte comeback alongside six brand‑new fall drinks, sparking immediate consumer buzz.
Shooting involving at least one officer after disturbance at Lodi McDonald's, police say
A police shooting following an armed disturbance inside a Lodi McDonald's has drawn heavy local media attention.
FDA Approves Alzheimer’s Blood Test Developed by Roche and Eli Lilly
The FDA has granted clearance to a new Alzheimer’s disease blood test developed by Roche and Eli Lilly.